Fact or fiction? Examining a role for N-methyl-D-aspartate receptor autoantibodies in psychiatric illness.
作者信息
Kayser Matthew S
机构信息
Departments of Psychiatry and Neuroscience, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania..
出版信息
Biol Psychiatry. 2015 Mar 15;77(6):506-7. doi: 10.1016/j.biopsych.2014.12.005.
Abstract
摘要
相似文献
1
Fact or fiction? Examining a role for N-methyl-D-aspartate receptor autoantibodies in psychiatric illness.
Biol Psychiatry. 2015 Mar 15;77(6):506-7. doi: 10.1016/j.biopsych.2014.12.005.
2
N-Methyl-D-Aspartate Receptor Autoantibodies in Psychiatric Illness.
Biol Psychiatry. 2016 May 1;79(9):e61. doi: 10.1016/j.biopsych.2015.03.034. Epub 2015 Jun 9.
3
Reply to: N-Methyl-D-Aspartate Receptor Autoantibodies in Psychiatric Illness.
Biol Psychiatry. 2016 May 1;79(9):e63. doi: 10.1016/j.biopsych.2015.05.023. Epub 2015 Jun 9.
4
Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children.
Biol Psychiatry. 2015 Mar 15;77(6):537-47. doi: 10.1016/j.biopsych.2014.07.014. Epub 2014 Jul 23.
5
Antibody mediated encephalitis.
J Neurol. 2013 Apr;260(4):1187-90. doi: 10.1007/s00415-013-6890-6.
6
N-Methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders.
Schizophr Res. 2015 Mar;162(1-3):291. doi: 10.1016/j.schres.2015.01.009. Epub 2015 Jan 15.
7
Response to Steiner and Bogerts on N-methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders.
Schizophr Res. 2015 Mar;162(1-3):292-3. doi: 10.1016/j.schres.2015.01.007. Epub 2015 Feb 4.
8
Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series.
Schizophr Res. 2014 Dec;160(1-3):193-5. doi: 10.1016/j.schres.2014.11.001. Epub 2014 Nov 15.
9
Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.
Brain. 2012 Nov;135(Pt 11):3453-68. doi: 10.1093/brain/aws256. Epub 2012 Oct 11.
10
Prevalence of serum N-methyl-D-aspartate receptor autoantibodies in refractory psychosis.
Br J Psychiatry. 2015 Feb;206(2):164-5. doi: 10.1192/bjp.bp.113.142216. Epub 2014 Nov 27.
引用本文的文献
1
Skewing of the antibody repertoire in cerebrospinal fluid B cells from healthy controls and patients with schizophrenia.
Behav Brain Res. 2022 Mar 26;422:113743. doi: 10.1016/j.bbr.2022.113743. Epub 2022 Jan 7.
2
Optimization of an Anti-NMDA Receptor Autoantibody Diagnostic Bioassay.
Front Neurol. 2018 Aug 22;9:661. doi: 10.3389/fneur.2018.00661. eCollection 2018.
3
Psychosis: an autoimmune disease?
Immunology. 2017 Nov;152(3):388-401. doi: 10.1111/imm.12795. Epub 2017 Aug 3.
4
Synaptic and Neuronal Autoantibody-Associated Psychiatric Syndromes: Controversies and Hypotheses.
Front Psychiatry. 2017 Feb 6;8:13. doi: 10.3389/fpsyt.2017.00013. eCollection 2017.
5
Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications.
Psychopharmacology (Berl). 2016 May;233(9):1605-21. doi: 10.1007/s00213-015-4156-y. Epub 2015 Dec 14.
本文引用的文献
1
Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes.
J Neurol Neurosurg Psychiatry. 2015 Jul;86(7):708-13. doi: 10.1136/jnnp-2014-308736. Epub 2014 Sep 22.
2
Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children.
Biol Psychiatry. 2015 Mar 15;77(6):537-47. doi: 10.1016/j.biopsych.2014.07.014. Epub 2014 Jul 23.
3
Seroprevalence of autoantibodies against brain antigens in health and disease.
Ann Neurol. 2014 Jul;76(1):82-94. doi: 10.1002/ana.24189. Epub 2014 Jun 23.
4
Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.
Mol Psychiatry. 2014 Oct;19(10):1143-9. doi: 10.1038/mp.2013.110. Epub 2013 Sep 3.
5
Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis.
JAMA Neurol. 2013 Sep 1;70(9):1133-9. doi: 10.1001/jamaneurol.2013.3216.
6
Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
JAMA Psychiatry. 2013 Mar;70(3):271-8. doi: 10.1001/2013.jamapsychiatry.86.
7
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Lancet Neurol. 2013 Feb;12(2):157-65. doi: 10.1016/S1474-4422(12)70310-1. Epub 2013 Jan 3.
8
Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.
Am J Psychiatry. 2012 Oct;169(10):1120-1. doi: 10.1176/appi.ajp.2012.12050646.
9
Disease-relevant autoantibodies in first episode schizophrenia.
J Neurol. 2011 Apr;258(4):686-8. doi: 10.1007/s00415-010-5788-9. Epub 2010 Oct 26.
10
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Lancet Neurol. 2008 Dec;7(12):1091-8. doi: 10.1016/S1474-4422(08)70224-2. Epub 2008 Oct 11.
Zotero 插件